FDA IND approval for Zn-DTPA, new clinical agent for decorporation therapy of actinides.
D008671:Actinoid Series Elements / Q000378:metabolism*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D004369:Pentetic Acid / Q000627:therapeutic use*; D015032:Zinc / Q000627:therapeutic use
D008671:Actinoid Series Elements; D004369:Pentetic Acid; D015032:Zinc